![](/img/cover-not-exists.png)
Neoadjuvant endocrine therapy for ER+ DCIS reduces the size of disease and allows BCS with a low re-excision rate
Cartlidge, Christopher W.J., Johns, Neil, Fernandez-Cuadrado, Teresa, Dixon, J MichaelVolume:
44
Language:
english
Journal:
European Journal of Surgical Oncology
DOI:
10.1016/j.ejso.2018.02.113
Date:
June, 2018
File:
PDF, 54 KB
english, 2018